WNT5A and pulmonary fibrosis: Zhang and colleagues showed that MSC-Exos increased Wnt5a/BMP2-driven signaling and suppressed Wnt/β-catenin-dependent collagen deposition and EMT in inflamed and fibrotic lungs, which resulted in the attenuation of pulmonary fibrosis [36].